Experts have big hopes for these specialized drugs created by living cells. But they are expensive and hard to scale up, so even success will have limited impact on the virus.
No comments yet. Be the first to comment!
Users invited can see your content
- The Economist (2020)
- TechCrunch (2020)
(2020)
- The Conversation (2020)
- MIT Technology Review (2020)
- CNN (2020)
- BBC News (2020)
- TheHill (2020)
(2022)
- STAT (2021)
- Gizmodo (2021)
- STAT (2020)
- Science (2020)
- Science | AAAS (2020)
Related chunks with this resource
No comments yet. Be the first to comment!